Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant
John D Sheppard Jr1, Quan Dong Nguyen2, Dale W Usner3, Timothy L Comstock3, for the Fluocinolone Acetonide Uveitis Study Group1Eastern Virginia Medical School, Norfolk, VA, USA; 2Wilmer Ophthalmological Institute, Johns Hopkins University, Baltimore, MD, USA; 3Bausch and Lomb Incorporated, Rochester...
Saved in:
Main Authors: | Sheppard Jr JD, Nguyen QD, Usner DW, Comstock TL; Fluocinolone Acetonide Uveitis Study Group |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/6687c7d327ab4e0d8712e17d10f4d5af |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of noninfectious posterior uveitis with intravitreal drug therapy
by: Tan HY, et al.
Published: (2016) -
Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant
by: Jane S Myung, et al.
Published: (2010) -
Dexamethasone intravitreal implant for the treatment of noninfectious uveitis
by: Hunter RS, et al.
Published: (2011) -
Evaluating the Safety, Efficacy and Patient Acceptability of Intravitreal Fluocinolone Acetonide (0.2mcg/Day) Implant in the Treatment of Non-Infectious Uveitis Affecting the Posterior Segment
by: Steeples LR, et al.
Published: (2021) -
Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis
by: Tufail A, et al.
Published: (2018)